Screener
RenovoRx RNXT Q1 2026 earnings
Reported May 14, 2026 · After market close
Revenue$563.0KBeat by $93.5K
EPS-$0.08In line
Revenue estimate$469.5K
EPS estimate-$0.08
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$952.0K
EPS estimate-$0.05
Versus estimates
Revenue
Diluted EPS
FAQ
- When did RenovoRx report Q1 2026 earnings?
- RenovoRx (RNXT) reported Q1 2026 earnings on May 14, 2026 after market close.
- What were RenovoRx's Q1 2026 revenue and EPS?
- RenovoRx reported revenue of $563.0K and eps of $-0.08 for Q1 2026.
- Did RenovoRx beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $469.5K by $93.5K. EPS beat the consensus estimate of $-0.08 by $0.00.
- How did RenovoRx's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 185.8% from $197.0K a year earlier and eps grew 0.0% from $-0.08.
- Where can I find RenovoRx's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-224080) and the 10-Q periodic report (0001193125-26-224100) directly on SEC EDGAR. The filing index links above go to sec.gov.
